DNA Link
Generated 5/10/2026
Executive Summary
DNA Link, operating as JS Link Sequencing Lab, is a US-based genomic research services company with its primary laboratory in Seoul, South Korea. Founded in 2000, the company provides comprehensive next-generation sequencing (NGS) and genomic analysis solutions to researchers globally. Leveraging a multi-platform infrastructure, DNA Link enables large-scale and technically challenging projects, including population genomics and novel genome assemblies. The company targets academic, pharmaceutical, and biotechnology clients, offering end-to-end services from sample preparation to data analysis. Despite being privately held and lacking disclosed financials, DNA Link has established a presence in the competitive genomics services market, differentiating through its focus on complex, high-throughput sequencing and its dual US-Korea operational base.
Upcoming Catalysts (preview)
- Q4 2026Major contract award for population-scale genomics project40% success
- 2026Strategic partnership or acquisition by larger life sciences tools company30% success
- Q2 2027Launch of new proprietary sequencing analysis platform20% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)